These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 17076304)

  • 61. Clozapine use in a forensic population in a New South Wales prison hospital.
    Martin A; O'Driscoll C; Samuels A
    Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study.
    Grover S; Chakrabarti S; Hazari N; Avasthi A
    Psychiatry Res; 2017 Mar; 249():349-353. PubMed ID: 28152470
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Supraventricular tachycardia in a patient receiving ECT, clozapine, and caffeine.
    Beale MD; Pritchett JT; Kellner CH
    Convuls Ther; 1994 Sep; 10(3):228-31. PubMed ID: 7834261
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clozapine in the management of bipolar and schizoaffective manic episodes resistant to standard treatment.
    Mahmood T; Devlin M; Silverstone T
    Aust N Z J Psychiatry; 1997 Jun; 31(3):424-6. PubMed ID: 9226089
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?
    Dursun SM; Hallak JE; Haddad P; Leahy A; Byrne A; Strickland PL; Anderson IM; Zuardi AW; Deakin JF
    J Psychopharmacol; 2005 Jul; 19(4):432-3. PubMed ID: 15983003
    [No Abstract]   [Full Text] [Related]  

  • 66. Epilepsy, psychosis and clozapine.
    Langosch JM; Trimble MR
    Hum Psychopharmacol; 2002 Mar; 17(2):115-9. PubMed ID: 12404701
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Strategies for optimizing stimulus dosage during electroconvulsive therapy].
    Gazdag G; Tolna J; Iványi Z
    Psychiatr Hung; 2007; 22(3):185-90. PubMed ID: 18167415
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Body mass index identified as an independent predictor of psychiatric readmission.
    Manu P; Khan S; Radhakrishnan R; Russ MJ; Kane JM; Correll CU
    J Clin Psychiatry; 2014 Jun; 75(6):e573-7. PubMed ID: 25004198
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Concurrent use of clozapine and valproate in affective and psychotic disorders.
    Kando JC; Tohen M; Castillo J; Centorrino F
    J Clin Psychiatry; 1994 Jun; 55(6):255-7. PubMed ID: 8071281
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials.
    Zheng W; Cao XL; Ungvari GS; Xiang YQ; Guo T; Liu ZR; Wang YY; Forester BP; Seiner SJ; Xiang YT
    PLoS One; 2016; 11(6):e0156510. PubMed ID: 27285996
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 72. Reasons for referral for electroconvulsive therapy: a comparison between adolescents and adults.
    Bloch Y; Sobol D; Levkovitz Y; Kron S; Ratzoni G
    Australas Psychiatry; 2008 Jun; 16(3):191-4. PubMed ID: 18568625
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antipsychotic polypharmacy in a treatment-refractory schizophrenia population receiving adjunctive treatment with electroconvulsive therapy.
    Kristensen D; Hageman I; Bauer J; Jørgensen MB; Correll CU
    J ECT; 2013 Dec; 29(4):271-6. PubMed ID: 23859980
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).
    Moulier V; Krir MW; Dalmont M; ; Guillin O; Rothärmel M
    Trials; 2021 Apr; 22(1):284. PubMed ID: 33858488
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
    Hatta K; Miyakawa K; Ota T; Usui C; Nakamura H; Arai H
    J ECT; 2007 Dec; 23(4):233-5. PubMed ID: 18090694
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study.
    Kreinin A; Epshtein S; Sheinkman A; Tell E
    Isr J Psychiatry Relat Sci; 2005; 42(1):61-3. PubMed ID: 16134408
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clozapine resistance: augmentation strategies.
    Porcelli S; Balzarro B; Serretti A
    Eur Neuropsychopharmacol; 2012 Mar; 22(3):165-82. PubMed ID: 21906915
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression.
    Hamoda HM; Osser DN
    Harv Rev Psychiatry; 2008; 16(4):235-47. PubMed ID: 18661366
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.